NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for SUNPHARMA is Neutral → (mild move); technical trend raise-2026-06-17; trading at ₹1,945.80 (-0.42% today); neutral (RSI 62).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | RAISE-2026-06-17 |
| Price | ₹1,945.80 |
| Change today | -0.42% |
| RSI (14) | 61.60 |
| Relative volume | 0.18 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹4.63 Lakh Cr |
| P/E | 38.27 |
| Cap category | Mega Cap |
| 52-week high | -0.8% away |
| 52-week low | +25.6% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for SUNPHARMA (Sun Pharmaceutical Industries Limited) is Neutral with a mild move, and its technical trend is raise-2026-06-17. The composite score and full factor breakdown are available to signed-in members.
SUNPHARMA's RSI is neutral (RSI 62). A reading above 70 is typically overbought and below 30 oversold.
SUNPHARMA is trading about 1% below its 52-week high and 26% above its 52-week low as of Aug 14 2026, 6:50 PM.
SUNPHARMA's market capitalisation is ₹4.63 Lakh Cr as of Aug 14 2026, 6:50 PM.
SUNPHARMA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.